Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04227197 · ClinicalTrials.gov registry record · NA

An Online Health Tool About Down Syndrome: Down Syndrome Clinic to You

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
281
Enrollment target

NCT04227197: Completed NA study, sponsored by Massachusetts General Hospital.

NCT04227197 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 281 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04227197, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
281 participants
Enrollment target

Study Summary

The investigators conducted a national two-arm, randomized controlled trial of caregivers of individuals with DS to assess the efficacy of DSC2U in assuring adherence to evidence-based guidelines. The research plan was approved by the Partners Human Research Committee.

Primary Outcome

Adherence to the five health evaluations indicated by national guidelines for Down syndrome. The five health evaluations included: celiac screen, sleep study, thyroid test, audiogram, and ophthalmology evaluation.

Interventions

  • OTHER Down Syndrome Clinic to You (DSC2U)

Trial Details

FieldValue
Enrollment Target 281 participants
Start Date 2017-10-03
Est. Completion 2019-05-15
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT04227197 record still lists

NCT04227197 is an interventional study that assigns participants to a tested intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 1 intervention - of which Down Syndrome Clinic to You (DSC2U) is the first listed.

NCT04227197 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04227197 about?

NCT04227197 is a clinical study titled "An Online Health Tool About Down Syndrome: Down Syndrome Clinic to You". The investigators conducted a national two-arm, randomized controlled trial of caregivers of individuals with DS to assess the efficacy of DSC2U in assuring adherence to evidence-based guidelines. The research plan was approved by the Partners Human Research Committee.

What is the current status of trial NCT04227197?

This trial is currently completed. It is a NA study. The enrollment target is 281 participants. The study started on 2017-10-03. Estimated completion is 2019-05-15.

What interventions are being tested in trial NCT04227197?

The interventions under investigation include: Down Syndrome Clinic to You (DSC2U) (OTHER).

Who is sponsoring clinical trial NCT04227197?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04227197's enrollment target sits among peer trials

281 380th of 2000 higher than 1,621 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04521231 · 281 participants · Phase 1

    A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

  • NCT06190730 · 281 participants · NA

    REmote Symptom COllection to improVE postopeRative Care

  • NCT02860364 · 282 participants · NA

    Comparing Hypothermic Temperatures During Hemiarch Surgery

  • NCT04867395 · 282 participants · NA

    A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04227197, the US trial registry maintained by the National Library of Medicine. NCT04227197 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.